Endosane Pharmaceuticals

Endosane Pharmaceuticals GmbH is a Berlin-based pharmaceutical company dedicated to the development and commercialization of novel finished drugs for the treatment of neurological, neuropsychiatric, and psychiatric disorders. In doing so, Endosane is systematically exploring the potential of the endogenous cannabinoid system to modulate neurophysiological balance. The current portfolio of compounds includes treatments for a variety of indications, including schizophrenia, social anxiety disorder, and post-traumatic stress disorder.